Professor Allan Evans

Professor Allan Evans

 

Provost & Chief Academic Officer

Allan graduated in 1982 with a Bachelor of Pharmacy at the South Australian Institute of Technology, UniSA’s antecedent institution. In 1989, he obtained his PhD in clinical pharmacology from the University of Adelaide. He followed this with post-doctoral experience at the University of Manchester, UK.

Allan has been an academic at UniSA for over 20 years, taking on various leadership positions including Senior Lecturer and Associate Professor. He was promoted to Professor in Pharmaceutics in 2003. The following year, he became Head of the School of Pharmacy and Medical Sciences, where he was instrumental in establishing the Sansom Institute (now the Division-based Sansom Institute for Health Research) and in supporting tremendous growth in the School’s research activity and teaching profile. In 2009, he became Pro Vice Chancellor and Vice President: Division of Health Sciences. Through his leadership, the Division registered significant growth in student numbers and experienced sustained improvement in research activity. In 2013, Allan was appointed UniSA’s first Provost & Chief Academic Officer. As Provost, he is responsible for enhancing UniSA’s educational offerings, providing an outstanding student experience, and planning and development of the University’s academic programs. Since assuming office, Allan has launched a whole-of-University review of the curriculum to examine the overall disciplinary profile of each School focusing on teaching quality, student engagement and satisfaction, and the uptake of the University’s blended and external delivery.

Allan has a significant research career. He has more than 100 peer-reviewed publications with over 1,400 literature citations and has held NHMRC and/or ARC grants on an ongoing basis since 1994. His research interests are broad, and include basic, clinical and commercial research into the better use of medicines as well as the development of new ways of using medicines to treat skin cancer and kidney disease. Allan’s group has attracted over $15 million in Category 1-4 research income to UniSA. Allan is former President of the Australasian Pharmaceutical Science Association (APSA) and winner of the APSA medal for outstanding contributions to pharmaceutical science.

Allan is currently non-executive Director of CPR Pharma Services Ltd, a spin-off company that he helped to form in 2009. He has a keen interest in supporting innovation in the health and medical sector and encouraging entrepreneurial activity within UniSA.

Areas of study and research

+ Click to minimise